← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Ecolab combined modest growth with higher profit, margin and free cash flow, reinforcing the recurring value of water, hygiene and process expertise.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 2.2%OK
- Profitability — Net income declined 1.7% to $2.076B from $2.112BWatch
- Cash flow — Free cash flow grew 4.7% to $1.904B from $1.819BOK
- Margins — Operating margin contracted 78 bps to 17.02%Watch
- Accounting — Steady profitable growth with resilient cash flowNote
- Insiders — 6 purchases and 12 salesOK
Business
Ecolab provides water, hygiene and infection-prevention products, equipment and services.
Where the revenue comes from
Fiscal 2025, as ECOLAB INC. reports it. History and quarterly detail are in the app.
- Water Services$8.0B
- Global Institutional$6.1B
- Global Healthcare And Life Sciences$747.9M
Leadership changes
From ECOLAB INC.'s own filings, the day they're filed.
- Christophe Beck · Chief Operating Officer · appointmenteff. 2026-04-01
- Victoria J. Reich · Directors · departureeff. 2026-02-18
- Julie P. Whalen · Chief Financial Officer · departureeff. 2025-08-06
Latest filings
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-07-28
- 8-K · Company announcement2026-05-29
- 8-K · Company announcement2026-05-11
- 10-Q · Quarterly report2026-05-07
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about ECOLAB INC., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.